Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: A randomised, open trial in 23 patients

Radiotherapy and Oncology

Volumn 45, Issue 2, 1997, Pages 125-128

  Aass, Nina ^a   Håtun, Dag Eirik ^b   Thoresen, Magne ^c   Fosså, Sophie D ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Sandoz Pharma AS   (Norway)

^c Medstat Research   (Norway)

Author keywords

Anti emetics; Radiotherapy; Seminoma; Tropisetron

Indexed keywords

METOCLOPRAMIDE; TROPISETRON;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEMINOMA; URTICARIA; VOMITING;

ADULT; ANTIEMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOLES; MALE; METOCLOPRAMIDE; NAUSEA; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SEMINOMA; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; VOMITING;

EID: 0031282140     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00099-6     Document Type: Article

References (11)

1. [1] Aass, N., Fosså, S.D. and Hoøst, H. Acute and subacute side effects due to infradiaphragmatic radiotherapy for testicular cancer: a prospective study. Int. J. Radiat. Oncol. J. Biol. Phys. 22: 1057-1064, 1992.
2. [2] Anderson, H., Thatcher, N., Howell, A., Logan, K., Sage, T. and de Bruijn, K.M. Tropisetron compared with a Metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting. Eur. J. Cancer 30A: 610-615, 1994.
3. [3] Chevallier, B. The control of acute cisplatin-induced emesis - comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group. Br. J. Cancer 68: 176-180, 1993.
4. [4] Fosså, S.D., Aass, N. and Kaalhus, O. Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients. Int. J. Radiat. Oncol. Biol. Phys. 16:383-388, 1989.
5. [5] Fossa, S.D., Horwich, A., Russell, J.M., Roberts, J.P., Jakes, R. and Stenning, S. Optimal field size in adjuvant radiotherapy (XRT) of stage I seminoma - a randomised trial. Proc. Am. Soc. Cancer Oncol. 15: 239, 1996.
6. [6] Gebbia, V., Testa. A., Valenza, R., Cannata, G., Tirroto, M.L. and Gebbia, N. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin based chemotherapy. A prospective randomized trial. Cancer 76: 1821-1828, 1995.
7. [7] Mirabell, R., Coucke, P., Behrouz, F. et al. Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of Tropisetron rescue for non-responders to Metoclopramide. Eur. J. Cancer 31A: 1461-1464, 1995.
8. [8] Peckham, M.J., Barrett, A., McElwain, T.J. and Hendry, W.P. Combined management of malignant teratoma of the testis. Lancet ii: 267-279, 1979.
9. [9] Sorbe, B. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. Ann. Oncol. 4: 39-42, 1993.
10. [10] Sorbe, B., Hallen, C. and Frankendal, B. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer Chemother. Pharmacol. 33: 298-302, 1994.
11. 3 receptor antagonist, with a Metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer 73: 445-454, 1994.